These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37332228)

  • 1. Long-term clinical outcomes of aspirin-exacerbated respiratory disease: Real-world data from an adult asthma cohort.
    Lee Y; Kim C; Lee E; Lee HY; Woo SD; You SC; Park RW; Park HS
    Clin Exp Allergy; 2023 Sep; 53(9):941-950. PubMed ID: 37332228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The utility of biomarkers in diagnosis of aspirin exacerbated respiratory disease.
    Comhair SAA; Bochenek G; Baicker-McKee S; Wang Z; Stachura T; Sanak M; Hammel JP; Hazen SL; Erzurum SC; Nizankowska-Mogilnicka E
    Respir Res; 2018 Oct; 19(1):210. PubMed ID: 30376852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomic analysis identifies potential diagnostic biomarkers for aspirin-exacerbated respiratory disease.
    Ban GY; Cho K; Kim SH; Yoon MK; Kim JH; Lee HY; Shin YS; Ye YM; Cho JY; Park HS
    Clin Exp Allergy; 2017 Jan; 47(1):37-47. PubMed ID: 27533637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of serum periostin with aspirin-exacerbated respiratory disease.
    Kim MA; Izuhara K; Ohta S; Ono J; Yoon MK; Ban GY; Yoo HS; Shin YS; Ye YM; Nahm DH; Park HS
    Ann Allergy Asthma Immunol; 2014 Sep; 113(3):314-20. PubMed ID: 25037608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Certain subphenotypes of aspirin-exacerbated respiratory disease distinguished by latent class analysis.
    Bochenek G; Kuschill-Dziurda J; Szafraniec K; Plutecka H; Szczeklik A; Nizankowska-Mogilnicka E
    J Allergy Clin Immunol; 2014 Jan; 133(1):98-103.e1-6. PubMed ID: 23993879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic hyperplastic eosinophilic sinusitis as a predictor of aspirin-exacerbated respiratory disease.
    Mascia K; Borish L; Patrie J; Hunt J; Phillips CD; Steinke JW
    Ann Allergy Asthma Immunol; 2005 Jun; 94(6):652-7. PubMed ID: 15984597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surfactant protein D alleviates eosinophil-mediated airway inflammation and remodeling in patients with aspirin-exacerbated respiratory disease.
    Choi Y; Lee DH; Trinh HKT; Ban GY; Park HK; Shin YS; Kim SH; Park HS
    Allergy; 2019 Jan; 74(1):78-88. PubMed ID: 29663427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Accuracy of Urinary LTE4 Measurement to Predict Aspirin-Exacerbated Respiratory Disease in Patients with Asthma.
    Bochenek G; Stachura T; Szafraniec K; Plutecka H; Sanak M; Nizankowska-Mogilnicka E; Sladek K
    J Allergy Clin Immunol Pract; 2018; 6(2):528-535. PubMed ID: 28888846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial folliculin enhances airway inflammation in aspirin-exacerbated respiratory disease.
    Trinh HKT; Pham DL; Choi Y; Kim HM; Kim SH; Park HS
    Clin Exp Allergy; 2018 Nov; 48(11):1464-1473. PubMed ID: 30126026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of TGF-β1 on eosinophils to induce cysteinyl leukotriene E4 production in aspirin-exacerbated respiratory disease.
    Choi Y; Sim S; Lee DH; Lee HR; Ban GY; Shin YS; Kim YK; Park HS
    PLoS One; 2021; 16(8):e0256237. PubMed ID: 34437574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of serine palmitoyl transferase and ORMDL3 polymorphism are associated with eosinophilic inflammation and airflow limitation in aspirin-exacerbated respiratory disease.
    Ban GY; Youn DY; Ye YM; Park HS
    PLoS One; 2020; 15(10):e0240334. PubMed ID: 33031402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of eosinophil-derived neurotoxin levels with asthma control status in patients with aspirin-exacerbated respiratory disease.
    Ban GY; Yang EM; Ye YM; Park HS
    Clin Transl Allergy; 2023 Mar; 13(3):e12229. PubMed ID: 36973950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential gene expression profile in PBMCs from subjects with AERD and ATA: a gene marker for AERD.
    Shin S; Park JS; Kim YJ; Oh T; An S; Park CS
    Mol Genet Genomics; 2012 May; 287(5):361-71. PubMed ID: 22457146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prominent role of IFN-γ in patients with aspirin-exacerbated respiratory disease.
    Steinke JW; Liu L; Huyett P; Negri J; Payne SC; Borish L
    J Allergy Clin Immunol; 2013 Oct; 132(4):856-65.e1-3. PubMed ID: 23806637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent Eosinophilic Inflammation in Adult Asthmatics with High Serum and Urine Levels of Leukotriene E
    Ban GY; Kim SH; Park HS
    J Asthma Allergy; 2021; 14():1219-1230. PubMed ID: 34675552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet activation markers overexpressed specifically in patients with aspirin-exacerbated respiratory disease.
    Mitsui C; Kajiwara K; Hayashi H; Ito J; Mita H; Ono E; Higashi N; Fukutomi Y; Sekiya K; Tsuburai T; Akiyama K; Yamamoto K; Taniguchi M
    J Allergy Clin Immunol; 2016 Feb; 137(2):400-11. PubMed ID: 26194538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevation of Eosinophil-Derived Neurotoxin in Plasma of the Subjects with Aspirin-Exacerbated Respiratory Disease: A Possible Peripheral Blood Protein Biomarker.
    Shin SW; Park JS; Park CS
    PLoS One; 2013; 8(6):e66644. PubMed ID: 23805255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin or other nonsteroidal inflammatory agent exacerbated asthma.
    Ledford DK; Wenzel SE; Lockey RF
    J Allergy Clin Immunol Pract; 2014; 2(6):653-7. PubMed ID: 25439353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophil activation and novel mediators in the aspirin-induced nasal response in AERD.
    Choi GS; Kim JH; Shin YS; Ye YM; Kim SH; Park HS
    Clin Exp Allergy; 2013 Jul; 43(7):730-40. PubMed ID: 23786280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma apolipoprotein H levels are different between aspirin induced respiratory diseases and aspirin tolerant asthma.
    Kim HJ; Park JS; Heo JS; Moon KY; Park CS
    Pulm Pharmacol Ther; 2014 Apr; 27(2):184-9. PubMed ID: 24120690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.